[Clinical manifestation of confusion and hallucinations caused by an interaction between rasagiline and escitalopram].
Bandrés Liso
Ana Cristina
AC
Toyas Miazza
Carla
C
D000368:Aged; D017109:Akathisia, Drug-Induced / Q000209:etiology; D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000494:pharmacology; D015283:Citalopram / Q000009:adverse effects* / Q000494:pharmacology; D003221:Confusion / Q000139:chemically induced*; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy; D005260:Female; D006212:Hallucinations / Q000139:chemically induced*; D006801:Humans; D006850:Hydrocephalus, Normal Pressure / Q000150:complications; D007189:Indans / Q000009:adverse effects* / Q000494:pharmacology; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy; D012701:Serotonin / Q000502:physiology; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000494:pharmacology
D000978:Antiparkinson Agents; D015283:Citalopram; D007189:Indans; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; C031967:rasagiline